家庭输液治疗市场规模| 2028年统计报告

  • Report Code : TIPRE00004189
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 221
Buy Now

【研究报告】家庭输液治疗市场预计将从2022年的217.6595亿美元增长到2028年的356.9605亿美元;预计 2022 年至 2028 年复合年增长率为 8.6%。

市场洞察和分析师观点:

家庭输液治疗涉及在家中向个体静脉内或皮下注射药物或生物制品。进行家庭输液所需的组件包括药物(抗病毒药物、免疫球蛋白)、设备(泵)和用品(管道和导管)。家庭输液过程通常需要多个实体之间的协调,包括患者、医生、出院计划者、健康计划、家庭输液药房以及家庭健康机构(如果适用)。慢性疾病发病率的增加和老年人口的增加正在推动家庭输液治疗市场的增长。

增长动力和挑战:

心血管、营养和胃肠道疾病、类风湿性关节炎和神经系统疾病等慢性疾病影响整体生活质量。据世界卫生组织 (WHO) 称,估计全球 50% 以上的人口患有至少一种慢性病。美国疾病控制与预防中心 (CDC) 表示,2019 年,美国每 10 个人中就有 6 人患有至少一种慢性疾病。根据罗马基金会全球研究结果《全球功能性胃肠道疾病的患病率和负担》 ,” 2021 年发表的一项大规模跨国研究显示,来自世界 33 个国家的 73,076 名成年人接受调查,其中约 40% 患有功能性胃肠道疾病 (GFID)。与年龄相关的胃肠道问题在64岁及以上的老年人群中更为常见。根据 2022 年发表的题为“印度成年人的胃肠道问题:印度纵向衰老研究的证据”的研究,自我报告的胃肠道疾病患病率约为 18%。研究还提到,世界各地肠胃问题的发生率各不相同,从伊朗的 14% 到一些西方国家的 54%。

心血管疾病 (CVD) ,特别是与忙碌的生活方式相关的病例,是全球死亡的一个重要原因。根据国际糖尿病联盟 (IDF) 的数据,2021 年,全球 20 岁至 79 岁的人群中有 5.37 亿人患有糖尿病,预计到 2045 年,这一数字将增至 7.83 亿。此外,糖尿病是 2019 年全球 670 万人死亡的原因。 2021 年。根据神经学联盟的数据,2019 年登记了约 1,470 万个神经系统病例,其中至少六分之一的人患有一种或多种神经系统疾病。

衰老会导致生理完整性持续丧失,导致功能下降和死亡风险增加。身体机能退化是老年患者感染大多数慢性疾病的关键危险因素,包括糖尿病、心血管疾病和神经系统疾病。根据 2019 年全球老龄化调查,65 岁或以上人口的出现频率可能会从 2019 年的每 11 名居民中就有 1 人增加到 2025 年的每 6 名居民中就有 1 人。预计到 2060 年,65 岁及以上人口将从 2016 年的 4600 万增加一倍,达到 9800 万以上,同期老年人口占全球人口的比例将从 15% 增加到约 24%。此外,除非洲外,所有地区的老龄化速度都将加快,到2050年,其人口中将有近四分之一或更多的人年龄在60岁及以上。因此,慢性病发病率的上升,加上老年人口的不断增长,推动了老龄化进程。家庭输液治疗市场的增长。

然而,在过去几年中,医疗机构收到了许多涉及输液泵的不良事件的报告,并导致产品召回。输液泵产品召回的主要原因是软件相关问题、用户界面问题以及机械和电气故障。例如,2022 年 4 月,Smiths Medical 因软件故障召回了超过 118,000 个 Medfusion 注射器输液泵(型号 3500 和 4000),因输注不足或过度或关键药物延迟交付而导致严重的患者伤害或死亡。患者。造成约七人重伤、一人死亡。同样,2020 年 12 月,FDA 宣布对超过 50 万台 Baxter Sigma 输液泵进行 1 级召回,原因是报警器缺陷导致 3 名患者死亡和 51 人重伤。因此,与家庭输液程序相关的安全问题和输液泵的召回阻碍了家庭输液治疗市场的增长。

战略见解

报告细分和范围:

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is meant by the home infusion therapy market?

Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. The components needed to perform home infusion include the drug (antivirals, immune globulin), equipment (a pump), and supplies (tubing and catheters). The home infusion process typically requires coordination among multiple entities, including patients, physicians, hospital discharge planners, health plans, home infusion pharmacies, and, if applicable, home health agencies.

What are the driving factors for the home infusion therapy market across the globe?

Key factors driving the market growth are increasing incidences of chronic disorders coupled with rising geriatric population and reduction in duration of hospital stays and surge in cost of care.

Which segment led the home infusion therapy market?

Based on product, the home infusion therapy market is segmented into infusion pump, intravenous sets, IV cannulas, and needleless connectors. The market for the infusion pumps segment is subsegmented into insulin pumps, elastomeric pumps, syringe pumps, and others. The infusion pumps segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period.

Which application segment held the largest revenue (US$ Mn) in the home infusion therapy market?

Based on application, the home infusion therapy market is segmented into enteral nutrition, anti-infective, endocrinology, hydration therapy, chemotherapy, specialty pharmaceuticals, and others. The anti-infective segment held the largest share of the market in 2021. The endocrinology segment is expected to record the highest CAGR during the forecast period.

What is the regional market scenario of the home infusion therapy market?

Global home infusion therapy market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the home infusion therapy market during 2022–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.

Who are the key players in the home infusion therapy market?

Companies operating in the market are B. Braun Melsungen AG, Micrel Medical Devices SA, Baxter International Inc, Nipro Corp, Becton Dickinson and Co, Fresenius Kabi AG, ICU Medical Inc, JMS Co Ltd, Eitan Medical Ltd, and Terumo Corp.

The List of Companies - Home Infusion Therapy Market:

  1. B. Braun Melsungen AG
  2. Micrel Medical Devices SA
  3. Baxter International Inc
  4. Nipro Corp
  5. Becton Dickinson and Co
  6. Fresenius Kabi AG
  7. ICU Medical Inc
  8. JMS Co Ltd
  9. Eitan Medical Ltd
  10. Terumo Corp

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports